Ligand validation:8BFW

LFI: 1-[3,5-bis(3-bromanylpropanoyl)-1,3,5-triazinan-1-yl]-3-bromanyl-propan-1-one

LFI is a Ligand Of Interest in 8BFW designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8BFW_LFI_D_101	16%	43%	0.265	0.865	0.57	1.67	-	3	0	0	86%	0.8571
8BFW_LFI_B_101	7%	72%	0.236	0.713	0.25	0.8	-	-	4	0	86%	0.8571
8BYJ_LFI_C_101	52%	51%	0.104	0.888	0.65	1.24	-	3	1	0	86%	0.8571
8QFZ_LFI_B_101	83%	18%	0.079	0.962	1.27	2.4	2	6	0	0	86%	0.8571
8B9P_LFI_C_101	58%	45%	0.121	0.926	0.7	1.44	-	2	0	0	86%	0.8571
8BN1_LFI_D_101	42%	39%	0.146	0.889	0.72	1.69	-	3	1	0	86%	0.8571

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.